San Francisco Finance Forum Panels on Funding Growth

The OneMedPlace 2008 Finance Forum has organized panels focused on funding the growth of healthcare and life science companies. These panels will include:      Negotiating the Venture Term Sheet This panel will examine the core principals of the term sheet and strategies for negotiating term sheets that...

[Video Profile] Ray Krauss, CEO of GlucoLight

Blood glucose levels have been called the next vital sign in the surgical environment. Numerous studies show that aggressive management of glucose levels in ICU patients results in a measurable reduction in complications, including mortality, length of hospital stay, and infection. Current testing methods,...

EDAP TMS’ Ablatherm Study Relevant to FDA Clinical Investigation

High Intensity Focused Ultrasound (HIFU) is competitive with currently accepted non-surgical standards of care, such as radiotherapy, but results in milder side effects, reveals the first long-term study of HIFU for the treatment of localized prostate cancer. In an editorial accompanying the published...

FDA Recommends Hologic’s Non-Incisional Approach to Tubal Ligation

Hologic’s Adiana provides a permanent transcervical alternative to tubal ligation. The procedure takes approximately 15 minutes and carries few of the side effects experienced during a more invasive surgical procedure. To date, Adiana has been evaluated in more than 600 women. Cytyc (subsequently acquired...

[Video Profile] Small Bone Innovations

The baby boomer generation and the aging global population are accelerating the growth of the orthopedic market. The percentage of the global population over the age of 60 will more than double between years 2000 and years 2050. People are working longer and remaining active for their whole lives, demanding...

DelSite to Challenge AstraZeneca’s Dominance of the Nasal Flu Vaccine Market

Current influenza vaccines use liquid formulations that have a limited shelf life, require refrigerated storage and, with the exception of AstraZeneca’s FluMist, are delivered by injection. FluMist is the only FDA approved nasal flu vaccine – AstraZeneca obtained the product through its $15.6 billion...

Rockland Technimed: Tissue Viability Imaging

Early detection of ischemic injury, though difficult to achieve, is becoming increasingly critical to the proper utilization of new interventional procedures. Experts note that although Magnetic Resonance Angiography can evaluate vessel anatomy and patency, the method cannot characterize tissue...

Scott Gill joins ISTO Technologies as Chief Financial Officer

Scott Gill has joined ISTO Technologies as Chief Financial Officer. Prior to joining ISTO, Mr. Gill was a Director in the Investment Banking group at A.G. Edwards & Sons.  In that capacity, he worked with a number of emerging public and private companies on a variety of capital raising and strategic...